WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H578009
CAS#: 143964-80-1
Description: F-1322 is an anti-asthmatic agent.
Hodoodo Cat#: H578009
Name: F-1322
CAS#: 143964-80-1
Chemical Formula: C37H37N3O4
Exact Mass: 587.28
Molecular Weight: 587.720
Elemental Analysis: C, 75.62; H, 6.35; N, 7.15; O, 10.89
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: F-1322; F 1322; F1322; NC-2000; NC 2000; NC2000; SOA 132; SOA-132; SOA132
IUPAC/Chemical Name: N-(2-(4-(Diphenylmethoxy)-1-piperidinyl)ethyl)-3-hydroxy-5-(3-pyridinylmethoxy)-2-naphthalenecarboxamide
InChi Key: ZBOYHAZRFJBUEL-UHFFFAOYSA-N
InChi Code: 1S/C37H37N3O4/c41-34-24-32-30(14-7-15-35(32)43-26-27-9-8-18-38-25-27)23-33(34)37(42)39-19-22-40-20-16-31(17-21-40)44-36(28-10-3-1-4-11-28)29-12-5-2-6-13-29/h1-15,18,23-25,31,36,41H,16-17,19-22,26H2,(H,39,42)
SMILES Code: Oc1cc2c(OCc3cccnc3)cccc2cc1C(=O)NCCN4CCC(CC4)OC(c5ccccc5)c6ccccc6
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: To be determined
Shelf Life: >2 years if stored properly
Drug Formulation: To be determined
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 587.72 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1. Mochizuki A, Tamura N, Yatabe Y, Onodera S, Hiruma T, Inaba N, Kusunoki J, Tomioka H. Suppressive effects of F-1322 on the antigen-induced late asthmatic response and pulmonary eosinophilia in guinea pigs. Eur J Pharmacol. 2001 Oct 26;430(1):123-33. doi: 10.1016/s0014-2999(01)01364-4. PMID: 11698072.
2. Lee B, Takasaki K, Mochizuki A, Tamura N, Higashide Y, Yamaura T. [Pharmacological profiles of F-1322, a novel anti-asthmatic agent. (1). Mechanisms of action]. Nihon Yakurigaku Zasshi. 1995 Jul;106(1):31-40. Japanese. doi: 10.1254/fpj.106.31. PMID: 7590521.
3. Mochizuki A, Lee B, Shibata M, Kasai M, Tanaka T, Iwamoto I. Inhibitory effect of F-1322 on allergic eosinophil infiltration in airways. Eur J Pharmacol. 1998 Feb 19;343(2-3):233-7. doi: 10.1016/s0014-2999(97)01534-3. PMID: 9570472.